Numerous studies have identified BRCA1 and BRCA2 (BRCA1/2) as important components of homologous recombination (HR), a specific DNA repair mechanism, in which mutations in these genes frequently lead to HRD in breast cancers [2, 3]. The gene discussed is BRCA1; the disease is breast cancer.